As we reported on a retrospective cohort, many MM cases show enhanced expression of pAkt and pErk, suggesting the activation of both PI3K/Akt/mTOR and RAS/MAPK pathways [16]; but the molecular basis of this activation remains unknown. This evidence concerns the gene AKT1 and Miyoshi myopathy.